US Stocks
Lumos Pharma Inc
Lumos Pharma Inc

Lumos Pharma Inc (LUMO)


  • $







Key Stats

Today Low/High$6.34 / $6.72
52 Week Low/High$6.3 / $20.49
Market Cap$54.99M

Company Details

Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé Ventures, and UCB. Lumos Pharma's lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, currently being evaluated in a Phase 2b clinical trial, the OraGrowtH210 Trial, for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to daily injections that current PGHD patients endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU.
OrganisationLumos Pharma Inc
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Lumos Pharma Inc (LUMO) share price today?

Can Indians buy Lumos Pharma Inc (LUMO) shares?

How can I buy Lumos Pharma Inc (LUMO) shares from India?

Can Fractional shares of Lumos Pharma Inc (LUMO) be purchased?

What are the documents required to start investing in Lumos Pharma Inc (LUMO) stocks?